Valvular heart disease (VHD) is a major contributor to loss of physical function, quality of life
and longevity. The epidemiology of VHD varies substantially around the world, with a …

Background Six billion people in low-and middle-income countries (LMICs) lack timely or
ready access to safe and affordable cardiac surgical care when needed, which remains a …

Background Congenital heart disease (CHD) is the leading cause of morbidity and mortality
from birth defects worldwide. We report an overview of trends in CHD mortality in 204 …

Cardiovascular disease continues to be one of the dominant causes of global mortality. One
effective treatment is to utilize cardiovascular implantable devices (cIMDs) with multi …

Summary Background Congenital birth defects (CBDs) present enormous challenges to
global healthcare systems. These conditions severely impact patients' health and …

China has the largest number of individuals with congenital heart disease (CHD) in the
world and a heavy burden of CHD. Therefore, understanding current CHD treatment …

We are in a “Brave New World” that is unchartered and open for progress and potential
paradigm shifts. What was supposed to be a memorable year for the American Association …

Although entirely preventable, rheumatic heart disease (RHD), a disease of poverty and
social disadvantage resulting in high morbidity and mortality, remains an ever-present …

Background Rheumatic heart disease (RHD) remains the leading cause of preventable
death and disability in children and young adults, killing an estimated 320,000 individuals …

BACKGROUND Assessment of chronic kidney disease (CKD) risk after acute kidney injury
(AKI) is based on limited markers primarily reflecting glomerular function. We evaluated …